Cargando…
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase
Mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by autoantibodies against the basal membrane zone of skin and surface-close epithelia and predominant mucosal lesions. The oral cavity and conjunctivae are most frequently affected, albeit clinical manifestations can...
Autores principales: | Patzelt, Sabrina, Pigors, Manuela, Steenbock, Heiko, Diel, Leonard, Boch, Katharina, Chakievska, Lenche, Künzel, Sven, Busch, Hauke, Fähnrich, Anke, Brinckmann, Jürgen, Schmidt, Enno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858800/ https://www.ncbi.nlm.nih.gov/pubmed/35197965 http://dx.doi.org/10.3389/fimmu.2021.812627 |
Ejemplares similares
-
Anti-Laminin 332-Type Mucous Membrane Pemphigoid
por: Shi, Luhuai, et al.
Publicado: (2022) -
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
por: Goletz, Stephanie, et al.
Publicado: (2021) -
Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
por: Chiorean, Roxana, et al.
Publicado: (2018) -
Autoimmunity against laminin 332
por: Patzelt, Sabrina, et al.
Publicado: (2023) -
Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin
por: TARNOWIETZKI, Evelyne, et al.
Publicado: (2020)